Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Share-based Compensation: 2021-2024

Historic Share-based Compensation for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $1.0 million.

  • Biofrontera's Share-based Compensation fell 18.06% to $236,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $961,000, marking a year-over-year increase of 1.37%. This contributed to the annual value of $1.0 million for FY2024, which is 2.49% down from last year.
  • According to the latest figures from FY2024, Biofrontera's Share-based Compensation is $1.0 million, which was down 2.49% from $1.0 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Share-based Compensation ranged from a high of $1.9 million in FY2022 and a low of $129,000 during FY2021.
  • Its 3-year average for Share-based Compensation is $1.3 million, with a median of $1.0 million in 2023.
  • In the last 5 years, Biofrontera's Share-based Compensation skyrocketed by 1,335.66% in 2022 and then crashed by 43.57% in 2023.
  • Over the past 4 years, Biofrontera's Share-based Compensation (Yearly) stood at $129,000 in 2021, then surged by 1,335.66% to $1.9 million in 2022, then plummeted by 43.57% to $1.0 million in 2023, then fell by 2.49% to $1.0 million in 2024.